Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Animal cell – per se – expressing immunoglobulin – antibody – or...
Reexamination Certificate
2011-07-05
2011-07-05
Haddad, Maher (Department: 1644)
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
Animal cell, per se, expressing immunoglobulin, antibody, or...
C530S388220, C530S387100, C530S387300
Reexamination Certificate
active
07972846
ABSTRACT:
The present invention relates to Cadherin-11 antagonists and compositions comprising Cadherin-11 antagonists. The invention also relates to methods for treating inflammatory joint disorders, such as rheumatoid arthritis, in a mammalian subject by administering a therapeutically effective amount of a Cadherin-11 antagonist.
REFERENCES:
patent: 5859205 (1999-01-01), Adair et al.
patent: 6358920 (2002-03-01), Blaschuk et al.
patent: 6433149 (2002-08-01), Blaschuk et al.
patent: 6472367 (2002-10-01), Blaschuk et al.
patent: 6569996 (2003-05-01), Blaschuk et al.
patent: 6593297 (2003-07-01), Blaschuk et al.
patent: 6638911 (2003-10-01), Blaschuk et al.
patent: 6680175 (2004-01-01), Blaschuk et al.
patent: 6682901 (2004-01-01), Blaschuk et al.
patent: 6962969 (2005-11-01), Blaschuk et al.
patent: 2003/0096746 (2003-05-01), Blaschuk et al.
patent: 2003/0229199 (2003-12-01), Blaschuk et al.
patent: 2004/0229811 (2004-11-01), Blaschuk et al.
patent: 2004/0248219 (2004-12-01), Blaschuk et al.
patent: 2004/0248220 (2004-12-01), Blaschuk et al.
patent: 2005/0215482 (2005-09-01), Blaschuk et al.
patent: WO 99/57149 (1999-11-01), None
patent: WO 01/17557 (2001-03-01), None
patent: WO 2004/048411 (2004-06-01), None
Geli et al., Recognition of the colicin A N-terminal epitope 1C11 in vitro and in vivo inEscherichia coliby its cognate monoclonal antibody. FEMS Microbiol Lett. May 15, 1993;109(2-3):335-42.
Katafiasz et al. Characterization of Cadherin-24, a Novel Alternatively Spliced Type II Cadherin. JBC 278(30):27513-27519, 2003.
Eduardo Padlan. Anatomy of the antibody molecule. Mol Immunol. Feb. 1994;31(3):169-217.
Vajdos et al. Comprehensive functional maps of the antigen-binding site of an anti-ErbB2 antibody obtained with shotgun scanning mutagenesis J. Mol. Biol. Jul. 5, 2002, 320(2):415-28.
Lederman S, et al. A single amino acid substitution in a common African allele of the CD4 molecule ablates binding of the monoclonal antibody, OKT4. Mol Immunol. 28(11):1171-81, 1991.
Chappuis-Flament, S., et al., “Multiple Cadherin Extracellular Repeats Mediate Homophilic Binding and Adhesion,”The Journal of Cell Biology154(1):231-243 (2001).
Hoet, R.M., et al., “Generation of High-affinity Human Antibodies by Combining Donor-derived and Synthetic Complementarity-determining-region Diversity,”Nature Biotechnology23(3):344-348 (2005).
Kiener, H.P., et al. “Building the Synovium: Cadherin-11 Mediates Fibroblast-like Synoviocyte Cell-to-Cell Adhesion,”Arthritis Res. Ther.7:49-54 (2005).
Kiener, H.P., et al. “Cadherin-11 Induces Rheumatoid Arthritis Fibroblast-Like Synoviocytes to Form Lining Layers in Vitro,”American Journal of Pathology168(5):1486-1499 (2006).
Lec, D.M., et al., “Cadherin-11 in Synovial Lining Formation and Pathology in Arthritis,”Science315:1006-1010 (2007).
May, C., et al., “Identification of a Transiently Exposed VE-cadherin Epitope that Allows for Specific Targeting of an Antibody to the Tumor Neovasculature,”Blood105(11):4337-4344 (2005).
Okazaki, M., et al., “Molecular Cloning and Characertization of OB-cadherin, a New Member of Cadherin Family Expressed in Osteoblasts,”The Journal of Biological Chemistry269(16):12092-12098 (1994).
Patel, S.D., et al., “Type II Cadherin Ectodomain Structures: Implications for Classical Cadherin Specificity,”Cell124:1255-1268 (2006).
Rauchenberger, R., et al., “Human Combinatorial Fab Library Yielding Specific and Functional Antibodies Against the Human Fibroblast Growth Factor Receptor 3,”The Journal of Biological Chemistry278(40):38194-38205 (2003).
Shan, W., et al., “The Minimal Essential Unit for Cadherin-mediated Intercellular Adhesion Comprises Extracellular Domains 1 and 2,”The Journal of Biological Chemistry279(53):55914-55923 (2004).
Valencia, X., et al., “Cadherin-11 Provides Specific Cellular Adhesion Between Fibroblast-like Synoviocytes,”J. Exp. Med.200(12):1673-1679 (2004).
Zhu, B., et al., “Functional Analysis of the Structural Basis of Homophilic Cadherin Adhesion,”Biophysical Journal84:4033-4042 (2003).
Invitation to Pay Additional Fees and, Where Applicable, Protest Fee—Annex to Form PCT/ISA/206 Communication Relating to the Results of the Partial International Search Report from PCT/US2009/000162, 10 pages (2009).
International Search Report from International Application No. PCT/US2009/000162; Dated: Aug. 5, 2009.
Written Opinion of the International Searching Authority from International Application No. PCT/US2009/000162; Date: Aug. 5, 2009.
Haddad Maher
Hamilton Brook Smith & Reynolds P.C.
Synovex Corporation
LandOfFree
Cadherin-11 antagonists and methods for the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cadherin-11 antagonists and methods for the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cadherin-11 antagonists and methods for the treatment of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2726759